|
|
|
|
|
|
|
Actinium Pharmaceuticals Inc (ATNM)
|
|
0.378 0 (0%)
|
05-22 10:11
|
|
Open:
|
0.379
|
Pre. Close:
|
0.378
|
|
High:
|
0.3799
|
Low:
|
0.37
|
|
Volume:
|
84,642
|
Market Cap:
|
42M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
0.401 - 0.403
|
0.403 - 0.404
|
|
Low:
|
0.375 - 0.378
|
0.378 - 0.379
|
|
Close:
|
0.377 - 0.38
|
0.38 - 0.383
|
|
|
|
Technical analysis (as of: 2018-05-22 10:02:49 AM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 0.48 One year: 0.56
|
|
Support:
|
Support1: 0.36 Support2: 0.33
|
|
Resistance:
|
Resistance1:
0.41 Resistance2: 0.48
|
|
Pivot:
|
0.37 
|
|
Moving Averages:
|
MA(5): 0.38 MA(20): 0.36
MA(100): 0.50 MA(250): 0.68
|
|
MACD:
|
MACD(12,26):
Signal(12,26,9):
|
|
%K %D:
|
%K(14,3): 62.25 %D(3): 63.22
|
|
RSI:
|
RSI(14): 53.37
|
|
52-Week:
|
High: 1.5
Low: 0.332 Change(%): -73.2
|
|
Average Vol(K):
|
3-Month: 93571
10-Days 101594
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.ATNM has closed below upper band by 29.1%. Bollinger Bands are 49% narrower than normal. The narrow width of the bands suggests low volatility as compared to ATNM's normal range. The bands have been in this narrow range for 36 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-05-04T05:00:00-04:00
Actinium Pharmaceuticals: Neglected Assets In Niche Oncology
2018-04-06T07:14:53-04:00
Key events next week - healthcare
2018-03-16T10:26:29-04:00
Key events next week - healthcare (continued #1)
2018-03-01T13:42:55-05:00
3 Things In Biotech You Should Learn Today: February 28, 2018
2018-02-28T08:30:00-05:00
Your Daily Pharma Scoop: Clovis Q4 Results, Endocyte Update, Merrimack Doses First Patient In MM-121 Mid-Stage Study
2018-02-26T11:25:37-05:00
Actinium Pharma down 18% after discounting rights offering
2018-02-10T08:37:29-05:00
Stocks To Watch: Digging For Gems In The Shakeout
2017-12-06T12:09:51-05:00
B. Riley likes Actinium, sees a four-bagger
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
